Abstract:Hearing loss is a common sensory disorder that has been a serious concern globally.It is recently estimated that around 466 million people worldwide have disabling hearing loss, including 34 million children, and this number will increase to over 900 million by 2050 (according to WHO report 2018).The majority of hearing disorders occur due to the death of either inner ear hair cells (HCs) or spiral ganglion neurons (SGNs), thus leading to sensorial neural hearing loss (SNHL).SNHL is known as the most common form of hearing disorder that comprises about 85% of all hearing loss cases.This type of damage is induced by a variety of reasons such as inner ear trauma, ischemia, ototoxic drugs, noise exposure, inflammation, viral infections, genetic deficits, autoimmunologic reaction, and aging.SNHL is generally not reversible due to the lack of regeneration capacity of HCs and SGNs.However, various recent studies have determined that the HCs and SGNs hold a regenerative potential and it is possible to find the cure for SNHL in the near future.This is supported by the clear understanding of the genetical control and signaling pathways involved in the development of HCs and SGNs and their functions, the regenerative potential of residing adult stem cells, and the development of gene therapy and the clinical trials of new pharmaceutical compounds on damaged cochleae.Last year, we have published the first special issue of "Hearing Loss: Reestablish the Neural Plasticity in Regenerated Spiral Ganglion Neurons and Sensory Hair Cells", and this year in this second special issue, we are presenting a new series of articles to report the most recent advances in several major areas as summarized below: HC development, HC damage and protection, HC regeneration, SGN development and protection, inherited hearing loss, and inner ear drug delivery.

Gene therapy: an emerging therapy for hair cells regeneration in the cochlea

Potential of Gene and Cell Therapy for Inner Ear Hair Cells

Atoh1 and Other Related Key Regulators in the Development of Auditory Sensory Epithelium in the Mammalian Inner Ear: Function and Interplay

Cochlear Gene Therapy for Sensorineural Hearing Loss: Current Status and Major Remaining Hurdles for Translational Success.

Molecular Mechanisms and Potentials for Differentiating Inner Ear Stem Cells into Sensory Hair Cells.

Stem Cell-Based Hair Cell Regeneration and Therapy in the Inner Ear

AAV-ie-K558R mediated cochlear gene therapy and hair cell regeneration

Approaches to Regenerate Hair Cell and Spiral Ganglion Neuron in the Inner Ear

Approaches to Treat Sensorineural Hearing Loss by Hair-Cell Regeneration: The Current State of Therapeutic Developments and Their Potential Impact on Audiological Clinical Practice

Milestones toward cochlear gene therapy for patients with hereditary hearing loss

Current AAV-mediated Gene Therapy in Sensorineural Hearing Loss

Manipulating cell fate in the cochlea: a feasible therapy for hearing loss

Stem Cells and Gene Therapy in Progressive Hearing Loss: the State of the Art

Advances in Molecular and Cellular Therapies for Hearing Loss

Gene therapy for deafness

Mammalian Cochlear Hair Cell Regeneration And Ribbon Synapse Reformation

Genetic Correction of Induced Pluripotent Stem Cells From a Deaf Patient With MYO7A Mutation Results in Morphologic and Functional Recovery of the Derived Hair Cell-Like Cells.

Stem Cells: A New Hope for Hearing Loss Therapy.

Generation of inner ear hair cells by direct lineage conversion of primary somatic cells

In situ regeneration of inner hair cells in the damaged cochlea by temporally regulated co-expression of Atoh1 and Tbx2

Hearing Loss: Reestablish the Neural Plasticity in Regenerated Spiral Ganglion Neurons and Sensory Hair Cells 2018